News
Using eXoZymes' AI-driven platform, a new and proprietary approach to biomanufacturing of NCT - with all the scale-up advantages of an exozyme biosolution - has been developed: Progressing from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results